As MASH is a multifactorial disease with triggers such as dyslipidemia, insulin resistance, inflammation, and oxidative stress, the roles of EP300 in these aspects of the disease were also explored. This evidence concerns the gene EP300 and metabolic dysfunction-associated steatohepatitis.